Immunopsychiatry: Investigating the role of inflammation in depression and other psychiatric disorders

One in three people with depression get no help from existing drugs, and a growing body of evidence points to the immune system as a hidden culprit. Depression is typically treated as a brain chemistry problem, but this approach fails for many patients. The research asks whether chronic inflammation—an overactive immune response—can actually cause depression, and whether it might also link depression to other psychiatric conditions. Using large-scale population data on symptoms, genetics, and blood biomarkers, the team will test four specific questions: whether inflammation triggers depression, what side effects might come from suppressing immune pathways, whether inflammation is a common thread across multiple mental illnesses, and whether there are inflammation-related subgroups within depression. If the work succeeds, it could redraw the map of psychiatric diagnosis. Rather than treating all depression as one disorder, clinicians might identify a distinct “inflammatory subtype” and target it with anti-inflammatory drugs or immune-modulating therapies. This would give a new treatment option to the millions who currently cycle through ineffective antidepressants. The research is still fundamental science—it is asking what causes what, not testing a drug—but it could shift how psychiatrists think about the immune system’s role in mental health.